Category Archives: Biomedicine

New $0.2 Centrifuge To Replace $1000 Worth Clinical Equipment

Centrifuges are the cornerstone of clinical labs to diagnosing diseases, but unfortunately they cost upwards of thousands of dollars and require electricity, making them useless in remote locations. However, a simple centuries old toy could be the answer to separating blood and plasma. Invented (or you could say discovered/repurposed) by Stanford scientists which includes Manu Prakash (who […]

xenopat

Xenopat: Your Tumor in a Mouse

Labcritics visited Xenopat, an innovative company dedicated to the orthotopic implantation of human tumors in mice. This technology allows Xenopat to offer services to companies developing new anticancer drugs and personalized cancer treatments. We had the pleasure of speaking with Dr. Anna Portela, CEO and co-founder, and Dr. Alberto Villanueva, CSO and co-founder. For more […]

iproteos

Teresa Tarragó: “Crowdfunding is a Source of Financing for Early Stage Biotechs”

Labcritics was at Iproteos’ facilities talking to Teresa Tarragó, CEO and co-founder of this innovative company. Iproteos combines computational chemistry with modern synthesis methods to generate peptidomimetics with pharmacological activity against diseases such as schizophrenia. We had the opportunity to know about the possibilities of crowdfunding for biotech projects and the technology used in their laboratory. […]

CROWDACURE: Crowdfunding Platform For Rare Diseases

A new website is trying to do what kickstarter has done for hundreds of entrepreneurs around the world in terms of gaining support for idea stage ventures. Crowdacure is helping researchers raise funds for “hard to fund” medical research. The hard to fund medical areas include tropical diseases, rare diseases and even common yet ignored […]

Quantification of Genome Editing Events Using ddPCR

Bio-Rad presented at Analytica the ultra-sensitive properties of digital droplet PCR (ddPCR) to quantify homology directed repair (HDR) and non-homologous end joining (NHEJ) events in genome editing experiments. Adam Bemis talked about the powerful applications of Bio-Rad’s QX200 Droplet Digital PCR in cutting-edge research and next-gen medicine. ddPCR divides the sample in thousands of droplets, […]

telomeres

BioViva’s CEO Claims to Have Longer Telomeres After Gene Therapy

BioViva reported last week that the company’s CEO, Elizabeth Parrish, successfully reversed biological ageing after being treated with the biotech’s therapies. The Seattle-based company confirmed that Parrish reversed 20 years of telomere shortening thanks to an experimental gene therapy. BioViva aims to provide regenerative medicine solutions through gene and cell therapies. The company is involved in several research lines to […]

Next Generation Sequencing

Study Identifies Individuals Resilient to Severe Genetic Diseases

Researchers from the Icahn School of Medicine at Mount Sinai in New York City have discovered that certain individuals have the ability to survive genetic disorders that usually have severe or lethal consequences. A genetic screen of almost 600000 healthy people identified 13 of them carrying mutations in essential genes. The study has been published in the […]

eSrtA. biofilm regeneration.

New Method to Extend the Lifetime of Implanted Devices

Researchers from Harvard University have developed a biochemical mechanism to extend the time that an implanted medical device can remain functional and not trigger an immune response. In a study published in Nature Communications, the authors engineered an enzyme to make it extremely efficient in replacing the biofilm that coats the devices and prevents unwanted physiological reactions. Medical […]